ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
212.00
+5.00 (2.42%)
Aug 1, 2025, 3:30 PM JST

ReproCELL Company Description

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan.

It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware.

The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services.

ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

ReproCELL Incorporated
CountryJapan
Founded2003
IndustryBiotechnology
SectorHealthcare
Employees99
CEOShuji Yokoyama

Contact Details

Address:
MetLife Shin-Yokohama Building
Yokohama, 222-0033
Japan
Phone81 45 475 3887
Websitereprocell.com

Stock Details

Ticker Symbol4978
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3974770004
SIC Code2836

Key Executives

NamePosition
Shuji YokoyamaChief Executive Officer
Daisuke UsuiChief Operating Officer